Previous 10 | Next 10 |
Hoth Therapeutics ([[HOTH]]) announces positive confirmatory results from in vivo model of HT-003 assets as potential treatment against acne.The model showed that HT-003 reduces the expression of toll-like receptor 2 ((TLR2)), one of the most critical pathways for acne pathophysiology.Th...
Hoth Therapeutics Announces Positive Confirmatory Results from In Vivo Model of HT-003 Assets as Potential Treatment Against Acne PR Newswire NEW YORK , July 13, 2021 /PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmace...
Hoth Therapeutics (HOTH) announces safety results in cohort 1 of its first in human clinical trial of the proprietary BioLexa platform to treat atopic dermatitis, also known as eczema.Shares up more than 8% premarket.The interim safety review indicates that BioLexa was wel...
Hoth Therapeutics Announces Positive Safety Results from AD001 Cohort 1 of Phase 1b Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis The primary objectives were achieved in cohort one BioLexa was well-tolerated with no treatment related adverse events Ini...
GreenApple78/iStock via Getty Images Hoth Therapeutics ([[HOTH]] -1.2%) has entered into an amendment to a license agreement signed with the U.S. Army Medical Research and Development Command (USAMRDC). Per the original agreement that became effective on December 22, 2020, USAMRDC granted the...
Hoth Therapeutics Announces Sponsored Research Agreement with Washington University for Novel Alzheimer's Therapeutic HT-ALZ PR Newswire NEW YORK , June 7, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical compan...
Hoth Therapeutics (HOTH) gains 4% premarket after announcing positive results from a preclinical trial, reinforcing the potential of HT-KIT, a new molecular entity under development for treatment of mast cell-derived cancers and anaphylaxis.The preclinical animal trials we...
Hoth Therapeutics Shares Positive Preclinical Results of Novel HT-KIT Therapeutic Shareholder Presentation Today to Further Highlight Results HT- KIT Reduces KIT expression and induces apoptosis of neoplastic human mast cells Inhibits tumor growth in humanized xenograft ...
Hoth Therapeutics Plans Shareholder Presentation on HT-KIT Therapeutic's Preclinical Results for Rare Cancers PR Newswire NEW YORK , June 1, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, ...
Hoth Therapeutics Announces Participation at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire NEW YORK , May 24, 2021 /PRNewswire/ -- Hoth Therapeutics , Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, ...
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NASDAQ Market:
Hoth Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment PR Newswire Treatment of pre-clinical subjects showed cognitive benefits that suggest HT-ALZ's mode of action may involve a reduction in brain inflammation, thereby improving cognitiv...